Objectives Although haematopoietic stem cells (HSCs) migrate to injured gut, therapeutic success clinically remains poor. This has been partially attributed to limited local HSC recruitment following systemic injection. Identifying site specific adhesive mechanisms underpinning HSC-endothelial interactions may provide important information on how to enhance their recruitment and thus potentially improve therapeutic efficacy. This study determined (i) the integrins and inflammatory cyto/chemokines governing HSC adhesion to injured gut and muscle (ii) whether pre-treating HSCs with these cyto/chemokines enhanced their adhesion and (iii) whether the degree of HSC adhesion influenced their ability to modulate leukocyte recruitment. Methods Adhesion of HPC-7, a murine HSC line, to ischaemia-reperfused (IR) injured mouse gut or cremaster muscle was monitored intravitally. Critical adhesion molecules were identified by pre-treating HPC-7 with blocking antibodies to CD18 and CD49d. To identify cyto/chemokines capable of recruiting HPC-7, adhesion was monitored following tissue exposure to TNF-α, IL-1β or CXCL12. The effects of pre-treating HPC-7 with these cyto/chemokines on surface integrin expression/clustering, adhesion to ICAM-1/VCAM-1 and recruitment in vivo was also investigated. Endogenous leukocyte adhesion following HPC-7 injection was again determined intravitally. Results IR injury increased HPC-7 adhesion in vivo, with intestinal adhesion dependent upon CD18 and muscle adhesion predominantly relying on CD49d. Only CXCL12 pre-treatment enhanced HPC-7 adhesion within injured gut, likely by increasing CD18 binding to ICAM-1 and/or CD18 surface clustering on HPC-7. Leukocyte adhesion was reduced at 4 hours post-reperfusion, but only when local HPC-7 adhesion was enhanced using CXCL12. Conclusion This data provides evidence that site-specific molecular mechanisms govern HPC-7 adhesion to injured tissue. Importantly, we show that HPC-7 adhesion is a modulatable event in IR injury and further demonstrate that adhesion instigated by injury alone is not sufficient for mediating anti-inflammatory effects. Enhancing local HSC presence may therefore be essential to realising their clinical potential.
References
[1]
Garcia-Gomez I, Elvira G, Zapata AG, Lamana ML, Ramirez M, et al. (2010) Mesenchymal stem cells: biological properties and clinical applications. Expert Opin Biol Ther 10: 1453–1468.
[2]
Otto WR, Wright NA (2011) Mesenchymal stem cells: from experiment to clinic. Fibrogenesis Tissue Repair 4: 20.
[3]
Oyama Y, Craig RM, Traynor AE, Quigley K, Statkute L, et al. (2005) Autologous hematopoietic stem cell transplantation in patients with refractory Crohn's disease. Gastroenterology 128: 552–563.
[4]
Schwarting S, Litwak S, Hao W, Bahr M, Weise J, et al. (2008) Hematopoietic stem cells reduce postischemic inflammation and ameliorate ischemic brain injury. Stroke 39: 2867–2875.
[5]
Granick JL, Simon SI, Borjesson DL (2012) Hematopoietic stem and progenitor cells as effectors in innate immunity. Bone Marrow Res 2012: 165107.
[6]
Allakhverdi Z, Delespesse G (2012) Hematopoietic progenitor cells are innate Th2 cytokine-producing cells. Allergy 67: 4–9.
[7]
Karp JM, Leng Teo GS (2009) Mesenchymal stem cell homing: the devil is in the details. Cell Stem Cell 4: 206–216.
[8]
Frenette PS, Subbarao S, Mazo IB, von Andrian UH, Wagner DD (1998) Endothelial selectins and vascular cell adhesion molecule-1 promote hematopoietic progenitor homing to bone marrow. Proc Natl Acad Sci USA 95: 14423–14428.
[9]
Turner ML, McIlwaine K, Anthony RS, Parker AC (1995) Differential Expression of Cell Adhesion Molecules by Human Hematopoietic Progenitor Cells from Bone Marrow and Mobilized Peripheral Blood. Stem Cells 13: 311–316.
[10]
Kavanagh DP, Durant LE, Crosby HA, Lalor PF, Frampton J, et al. (2010) Haematopoietic stem cell recruitment to injured murine liver sinusoids depends on (alpha)4(beta)1 integrin/VCAM-1 interactions. Gut 59: 79–87.
[11]
Papayannopoulou T, Craddock C, Nakamoto B, Priestley GV, Wolf NS (1995) The VLA4/VCAM-1 adhesion pathway defines contrasting mechanisms of lodgement of transplanted murine hemopoietic progenitors between bone marrow and spleen. Proc Natl Acad Sci USA 92: 9647–9651.
[12]
Kavanagh DP, Yemm AI, Alexander JS, Frampton J, Kalia N (2012) Enhancing the adhesion of haematopoietic precursor cell integrins with hydrogen peroxide increases recruitment within murine gut. Cell Transplant
[13]
Chen BP, Galy AM, Fraser C, Hill B (1997) Delineation of the human hematolymphoid system: potential applications of defined cell populations in cellular therapy. Immunol Rev 157: 41–51.
[14]
Katayama Y, Hidalgo A, Peired A, Frenette PS (2004) Integrin {alpha}4{beta}7 and its counterreceptor MAdCAM-1 contribute to hematopoietic progenitor recruitment into bone marrow following transplantation. Blood 104: 2020–2026.
[15]
Pinto do óP, Kolterud ？, Carlsson L (1998) Expression of the LIM-homeobox gene LH2 generates immortalized Steel factor-dependent multipotent hematopoietic precursors. EMBO Journal 17: 5744–5756.
[16]
Wilson NK, Miranda-Saavedra D, Kinston S, Bonadies N, Foster SD, et al. (2009) The transcriptional program controlled by the stem cell leukemia gene Scl/Tal1 during early embryonic hematopoietic development. Blood 113: 5456–5465.
[17]
Ross EA, Freeman S, Zhao Y, Dhanjal TS, Ross EJ, et al. (2008) A novel role for PECAM-1 (CD31) in regulating haematopoietic progenitor cell compartmentalization between the peripheral blood and bone marrow. PLoS ONE 3: e2338.
[18]
Morita Y, Ema H, Nakauchi H (2010) Heterogeneity and hierarchy within the most primitive hematopoietic stem cell compartment. J Exp Med 207: 1173–1182.
[19]
Matthews JN, Altman DG, Campbell MJ, Royston P (1990) Analysis of serial measurements in medical research. BMJ (Clinical Research Ed) 300: 230–235.
[20]
Oktar BK, Gulpinar MA, Bozkurt A, Ghandour S, Cetinel S, et al. (2002) Endothelin receptor blockers reduce I/R-induced intestinal mucosal injury: role of blood flow. Am J Physiol Gastrointest Liver Physiol 282: G647–655.
[21]
Fukatsu K, Ueno C, Maeshima Y, Hara E, Nagayoshi H, et al. (2004) Effects of L-arginine infusion during ischemia on gut blood perfusion, oxygen tension, and circulating myeloid cell activation in a murine gut ischemia/reperfusion model. JPEN J Parenter Enteral Nutr 28: 224–230; discussion 230–221.
[22]
Guan Y, Worrell RT, Pritts TA, Montrose MH (2009) Intestinal ischemia-reperfusion injury: reversible and irreversible damage imaged in vivo. Am J Physiol Gastrointest Liver Physiol 297: G187–196.
[23]
Mejia-Vilet JM, Ramirez V, Cruz C, Uribe N, Gamba G, et al. (2007) Renal ischemia-reperfusion injury is prevented by the mineralocorticoid receptor blocker spironolactone. Am J Physiol Renal Physiol 293: F78–86.
[24]
Henninger DD, Panes J, Eppihimer M, Russell J, Gerritsen M, et al. (1997) Cytokine-induced VCAM-1 and ICAM-1 expression in different organs of the mouse. J Immunol 158: 1825–1832.
[25]
Connor EM, Eppihimer MJ, Morise Z, Granger DN, Grisham MB (1999) Expression of mucosal addressin cell adhesion molecule-1 (MAdCAM-1) in acute and chronic inflammation. J Leukoc Biol 65: 349–355.
[26]
Esposito E, Mazzon E, Muia C, Meli R, Sessa E, et al. (2007) Splanchnic ischemia and reperfusion injury is reduced by genetic or pharmacological inhibition of TNF-alpha. J Leukoc Biol 81: 1032–1043.
[27]
Sumpio BE (2003) Atherosclerosis: Biological and Surgical Considerations. In: Ascher E, Hollier LH, Strandness DE, Towne JB, Calligaro K et al.., editors. Haimovici's Vascular Surgery. 5th ed: Wiley-Blackwell. pp. 137–163.
[28]
Souza DG, Lomez ES, Pinho V, Pesquero JB, Bader M, et al. (2004) Role of bradykinin B2 and B1 receptors in the local, remote, and systemic inflammatory responses that follow intestinal ischemia and reperfusion injury. J Immunol 172: 2542–2548.
[29]
Lundberg AH, Granger DN, Russell J, Sabek O, Henry J, et al. (2000) Quantitative measurement of P- and E-selectin adhesion molecules in acute pancreatitis: correlation with distant organ injury. Ann Surg 231: 213–222.
[30]
Playford RJ, Ghosh S (2005) Cytokines and growth factor modulators in intestinal inflammation and repair. J Pathol 205: 417–425.
[31]
Montecucco F, Steffens S, Burger F, Da Costa A, Bianchi G, et al. (2008) Tumor necrosis factor-alpha (TNF-alpha) induces integrin CD11b/CD18 (Mac-1) up-regulation and migration to the CC chemokine CCL3 (MIP-1alpha) on human neutrophils through defined signalling pathways. Cell Signal 20: 557–568.
[32]
Crisostomo PR, Wang Y, Markel TA, Wang M, Lahm T, et al. (2008) Human mesenchymal stem cells stimulated by TNF-alpha, LPS, or hypoxia produce growth factors by an NF kappa B- but not JNK-dependent mechanism. Am J Physiol Cell Physiol 294: C675–682.
[33]
Yoshida T, Hakuba N, Morizane I, Fujita K, Cao F, et al. (2007) Hematopoietic stem cells prevent hair cell death after transient cochlear ischemia through paracrine effects. Neuroscience 145: 923–930.
[34]
Pettipher ER, Higgs GA, Henderson B (1986) Interleukin 1 induces leukocyte infiltration and cartilage proteoglycan degradation in the synovial joint. Proc Natl Acad Sci USA 83: 8749–8753.
[35]
Orelio C, Peeters M, Haak E, van der Horn K, Dzierzak E (2009) Interleukin-1 regulates hematopoietic progenitor and stem cells in the midgestation mouse fetal liver. Haematologica 94: 462–469.
[36]
Kollet O, Shivtiel S, Chen YQ, Suriawinata J, Thung SN, et al. (2003) HGF, SDF-1, and MMP-9 are involved in stress-induced human CD34+ stem cell recruitment to the liver. J Clin Invest 112: 160–169.
[37]
Avigdor A, Goichberg P, Shivtiel S, Dar A, Peled A, et al. (2004) CD44 and hyaluronic acid cooperate with SDF-1 in the trafficking of human CD34+ stem/progenitor cells to bone marrow. Blood 103: 2981–2989.
[38]
Abbott JD, Huang Y, Liu D, Hickey R, Krause DS, et al. (2004) Stromal cell-derived factor-1alpha plays a critical role in stem cell recruitment to the heart after myocardial infarction but is not sufficient to induce homing in the absence of injury. Circulation 110: 3300–3305.
[39]
Peled A, Grabovsky V, Habler L, Sandbank J, Arenzana-Seisdedos F, et al. (1999) The chemokine SDF-1 stimulates integrin-mediated arrest of CD34(+) cells on vascular endothelium under shear flow. Journal of Clinical Investigation 104: 1199–1211.
[40]
Wyble CW, Hynes KL, Kuchibhotla J, Marcus BC, Hallahan D, et al. (1997) TNF-[alpha] and IL-1 Upregulate Membrane-Bound and Soluble E-Selectin through a Common Pathway. J Surg 73: 107–112.
[41]
Santiago B, Baleux F, Palao G, Gutierrez-Canas I, Ramirez JC, et al. (2006) CXCL12 is displayed by rheumatoid endothelial cells through its basic amino-terminal motif on heparan sulfate proteoglycans. Arthritis Res Ther 8: R43.
[42]
Yu T, Wu X, Gupta KB, Kucik DF (2010) Affinity, lateral mobility, and clustering contribute independently to beta 2-integrin-mediated adhesion. Am J Physiol Cell Physiol 299: C399–410.
[43]
Hiasa K-i, Ishibashi M, Ohtani K, Inoue S, Zhao Q, et al. (2004) Gene Transfer of Stromal Cell-Derived Factor-1α Enhances Ischemic Vasculogenesis and Angiogenesis via Vascular Endothelial Growth Factor/Endothelial Nitric Oxide Synthase-Related Pathway. Circulation 109: 2454–2461.
[44]
Khalil PN, Weiler V, Nelson PJ, Khalil MN, Moosmann S, et al. (2007) Nonmyeloablative stem cell therapy enhances microcirculation and tissue regeneration in murine inflammatory bowel disease. Gastroenterology 132: 944–954.
[45]
Mifflin RC, Pinchuk IV, Saada JI, Powell DW (2011) Intestinal myofibroblasts: targets for stem cell therapy. Am J Physiol Gastrointest Liver Physiol 300: G684–696.
[46]
Ratajczak MZ, Kucia M, Jadczyk T, Greco NJ, Wojakowski W, et al. (2012) Pivotal role of paracrine effects in stem cell therapies in regenerative medicine: can we translate stem cell-secreted paracrine factors and microvesicles into better therapeutic strategies? Leukemia 26: 1166–1173.
[47]
Kyriakides C, Austen WG, Wang Y, Favuzza J, Moore FD, et al. (2000) Neutrophil mediated remote organ injury after lower torso ischemia and reperfusion is selectin and complement dependent. J Trauma 48: 32–38.
